Masimo has obtained additional 510(k) clearance from the FDA for its O3 Regional Oximetry platform for use in neonates and infants. The system monitors the hemoglobin oxygen saturation of blood on both sides of the brain using near-infrared spectroscopy.
Masimo's O3 Regional Oximetry cleared by FDA for neonates, infants
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.